Cargando…
The Inhibitory Effects of New Zealand Pine Bark (Enzogenol(®)) on α-Amylase, α-Glucosidase, and Dipeptidyl Peptidase-4 (DPP-4) Enzymes
The New Zealand pine bark extract (Enzogenol(®)) has previously been shown to elicit acute hypoglycaemic effects in humans. The present study investigated the underlying mechanisms of Enzogenol(®) in reducing postprandial glucose in humans. The potential inhibitory action of Enzogenol(®) against dig...
Autores principales: | Lim, Wen Xin Janice, Gammon, Cheryl S., von Hurst, Pamela, Chepulis, Lynne, Page, Rachel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029645/ https://www.ncbi.nlm.nih.gov/pubmed/35458159 http://dx.doi.org/10.3390/nu14081596 |
Ejemplares similares
-
An Acute, Placebo-Controlled, Single-Blind, Crossover, Dose-Response, Exploratory Study to Assess the Effects of New Zealand Pine Bark Extract (Enzogenol(®)) on Glycaemic Responses in Healthy Participants
por: Lim, Wen Xin Janice, et al.
Publicado: (2020) -
α-Amylase and dipeptidyl peptidase-4 (DPP-4) inhibitory effects of Melicope latifolia bark extracts and identification of bioactive constituents using in vitro and in silico approaches
por: Quek, Alexandra, et al.
Publicado: (2021) -
Standardized Emblica officinalis fruit extract inhibited the activities of α‐amylase, α‐glucosidase, and dipeptidyl peptidase‐4 and displayed antioxidant potential
por: Majeed, Muhammed, et al.
Publicado: (2019) -
Synergistic effect of α‐glucosidase inhibitors and dipeptidyl peptidase 4 inhibitor treatment
por: Horikawa, Yukio, et al.
Publicado: (2010) -
Dipeptidyl peptidase-4 (DPP-4; CD26)
Publicado: (2013)